Word

SCIENION

Status

Registered

Status Code

800

Status Date

Friday, January 13, 2017

Serial Number

76350957

Registration Number

3152451

Registration Date

Tuesday, October 10, 2006

Mark Type

1000

Filing Date

Thursday, December 20, 2001

Published for Opposition

Tuesday, December 28, 2004

Trademark Owner History

Scienion AG - Original Registrant

Classifications

1 Chemical products for industrial and scientific purposes, namely, nucloic acids, peptides and proteins for scientific and research use in the fields of phannacology, foodstuffs, plant protection, cosmetics, diagnostics and biochemical and medical research; libraries of immobilized chemical compounds for scientific and research use in the fields of pharmacology, foodstuffs, plant protection, cosmetics, diagnostics and biochemical and medical research; arrays of chemical compounds, namely, nucleic acids, peptides and proteins for scientific and research use in the fields of pharmacology, foodstuffs, plant protection, cosmetics, diagnostics and biochemical and medical research; arrays of libraries of chemical compounds arranged on a support for scientific and research use in the fields of pharmacology, foodstuffs, plant protection, cosmetics, diagnostics and biochemical and medical research; chemical compounds produced by using immobilized chemical compounds, libraries of chemical compounds and arrays of chemical compounds, namely, such compounds which are immobilized on a support for scientific and research use in the fields of pharmacology, foodstuffs, plant protection, cosmetics, diagnostics and biochemical and medical research

5 [ Pharmaceutical and veterinary products, namely, antiseptics, slimming, appetite suppressants, pharmaceuticals for acidosis therapeutics, analeptic and antihypoxaemics; analgesics and antirheumatic drags, pharmaceuticals functioning as antihelmintics, antiallergics, antianemia drugs, antiarrhythmics, antibiotics and antiinfectives, antidementics, nootropics, antidiabetics, antidotes for the treatment of poisoning, antiemetics and antivertiginosics, antiepileptics, antihemorrhagics, antifibrinolyrics, hemostatics, antihypertonics, antihypoglycemics, antihypotonica, anlicoagulauts, antimycotics, pharmaceuticals functioning as antiparasitics, antiphiogistics, antitussives, expectorants for use in atherosclerosis, balneotherapeutics and pharmaceuticals for thermal therapy, pharmaceuticals functioning as beta receptor blocking agents, pharmaceuticals for calcium channel blocking and inhibiting of the renin angiotensin system, pharmaceuticals functioning as broncholytics, antiasthmetics cholagoguegics and for use in biliary tract therapeutics; pharmaceuticals functioning as cholinergics, corticoids, dermatics; all purpose disirifectants and antiseptics; pharmaceuticals functioning as dietetic agents and in alimentary therapeutics; diagnostic preparations functioning as diuretics, as agents for favoring blood flow, as withdrawal agents, as fibrinolytics, to treat gout, the flu and catarrhal fever; pharmaceuticals for the treatment of gynecological illnesses, namely, menstrual cramps, hemorrhoids, hepatitis; pharmaceuticals functioning as hypnotics and sedatives; pharmaceuticals to treat cardiac ailments; pharmaceuticals for use in caries and parodontosis; dental preparations, namely, dental abrasives; laxatives, pharmaceuticals functioning as antilipaemics, local anesthetics, neural therapeutics, gastro-ititestinal preparations, pharmaceuticals to treat migraines; pharmaceutical preparations for use in mouth and pharyngeal therapeutics; pharmaceuticals for use as muscle relaxants; pharmaceuticals for the treatment of addiction to narcotics; pharmaceuticals for use in neuropathology; ophthalmic pharmaceuticals for treating blindness, conjunctivitis, cataract, glaucoma, retinal detachment, stye, chalazion, dacryoadenitis, corneal clouding, keratitis, gasserian ganglionitis, vitreous opacity, amaurosis, retinopathy, central retinal artery occlusion, retinoblastoma, melanoma, optic neuritis, optic nerve atrophy; pharmaceuticals for use in osteoporosis and calcium metabolism modification; pharmaceuticals for the treatment of Parkinson's Disease and disturbances of the extrapyramidal system; pharmaceuticals for psychotropic, rhinologic and sinositic purposes; pharmaceuticals functioning as roborants and tonics; pharmaceuticals for use in thyroidal therapeutics; pharmaceuticals functioning as spasmolytics and inhibitors of thrombocyte aggregation; pharmaceuticals for the treatment of tuberculosis; pharmaceuticals functioning as alternants, urologics and venous agents; vitamins; pharmaceuticals for use as cytostatics and antineoplastic agents; homeopathic remedies for use in the treatment of salmonellosis, paratuberculosis and cancer; veterinary preparations for use in the treatment of diseases equivalent to salnionellosis, paratubeculosis and cancer; pharmaceutical and veterinary products, namely, antiseptics, slimming, appetite suppressants, pharmaceuticals for acidosis therapeutics, analeptic and antihypoxaemics; analgesics and antirhsuinatic drugs, pharmaceuticals functioning as antihelmintics, antiallergics, antianemia drugs, antiarrhythmics, antibiotics and antlinfectives, antidementics, nootropics, antidiabetics, antidotes for the treatment of poisoning, antiemetics and antivertiginosics; antiepileptics, antihermorrhagics, antifibrinolyrics, hemostatic; antihypertonics, antihypoglycomics, antihypotonica, anticoagulant; antimycotics, pharmaceuticals functioning as antiparasitics, antiphiogistics, antitussives, expectorants for use in atherosclerosis, balneotherapeutics and pharmaceuticals for thermal therapy, pharmaceuticals functioning as beta receptor blocking agents, pharmaceuticals for calcium channel blocking and inhibiting of the renin angiotensinir system, pharmaceuticals functioning as broncholytics, antiastlimetics cholagoguegics and for use in biliary tract therapeutics; pharmaceuticals functioning as cholinergics, corticoids, dermatics; all purpose disinfeetants and antiseptics; pharmaceuticals functioning as dietetic agents and in alimentary therapeutics; diagnostic preparations functioning as diuretics, as agents for favoring blood flow, as withdrawal agents, as fibrinolytics, to treat gout, the flu and catarrhal fever; pharmaceuticals for the treatment of gynecological illnesses, namely, menstrual cramps, hemorrhoids, hepatitis; pharmaceuticals functioning as hypnotics and sedatives; pharmaceuticals to treat cardiac ailments; pharmaceuticals for use in caries and parodontosis; dental preparations, namely, dental abrasives; laxatives, pharmaceuticals functioning as antilipaemics, local anesthetics, neural therapeutics, gastro- intestinal preparations, pharmaceuticals to treat migraines; pharmaceutical preparations for use in mouth and pharyngeal therapeutics; pharmaceuticals for use as muscle relaxants; pharmaceuticals for the treatment of addiction to narcotics; pharmaceuticals for use in neuropathology; ophthalmic pharmaceuticals for treating blindness, conjunctivitis, cataract, glaucoma, retinal detachment, stye, chalazion, daoryoadenitis, corneal clouding, keratitis, gasserian ganglionitis, vitreous opacity, amaurosis, retinopathy, central retinal artery occlusion, retinoblastoma, melanoma, optic neuritis, optic nerve atrophy; pharmaceuticals for use in osteoporosis and calcium metabolism modification; pharmaceuticals for the treatment of Parkinson's Disease and disturbances of the extrapyramidal system; pharmaceuticals for psychotropic, rhinologic and sinositic purposes; pharmaceuticals functioning as roborants and tonics; pharmaceuticals for use in thyroidal therapeutics; pharmaceuticals functioning as spasmolytics and inhibitors of thrombocyte aggregation; pharmaceuticals for the treatment of tuberculosis; pharmaceuticals functioning as alternants, urologica and venous agents; vitamins; pharmaceuticals for use as cytostatics and antineoplastic agents; homeopathic remedies far use in the treatment of salmonellosis, paratubereulosis and cancer; arrays of libraries of chemical compounds arranged on a support for clinical or medical laboratory use; chemical compounds arranged on a support for clinical or medical laboratory use; nutraceuticals for use in dietary supplements ]

9 Scientific measure and controlling apparatus and instruments; support materials, more particularly membranes and glass; scientific instruments and devices comprising support materials, more particularly membranes and glass, comprising chemical products for industrial and scientific purposes, more particularly nucleic acids, peptides and proteins, comprising immobilized chemical compounds, comprising libraries of chemical compounds for industrial and scientific purposes, more particularly immobilized chemical compounds for industrial and scientific purposes, comprising arrays of chemical compounds, more particularly of nucleic acids, peptides and proteins, comprising arrays of libraries of chemical compounds, more particularly libraries of chemical compounds arranged on a support, comprising compounds produced by using or by means of immobilized chemical compounds, libraries of chemical compounds or arrays of chemical compounds, more particularly such chemical compounds which are immobilized on a support, comprising chemical compounds for industrial and scientific purposes manufactured by using or by means of chemical products for industrial and scientific purposes, more particularly nucleic acids, peptides and proteins; computer software and programs, more particularly computer programs for synthesis and/or immobilization of chemical products for industrial and scientific purposes, more particularly nucleic acids, peptides and proteins, of immobilized chemical compounds, of arrays of libraries of chemical compounds, more particularly arrays of chemical compounds arranged on a support, of compounds manufactured with the aid of immobilized chemical compounds, libraries of chemical compounds or arrays of chemical compounds, more particularly such compounds which are immobilized on a support; computer software (saved), computer programs, more particularly computer programs for analysis of patterns of surfaces, more particularly of support materials like membranes and glass, more particularly such supports comprising chemical products for industrial and scientific purposes, more particularly nucleic acids, peptides and proteins, for analysis of immobilized chemical compounds, for analysis of chemical compounds for industrial and scientific purposes, for analysis of arrays of chemical compounds, more particularly of nucleic acids, peptides and proteins, for analysis of arrays of libraries of chemical compounds, more particularly libraries of chemical compounds arranged on a support, for analysis of compounds manufactured with the aid of immobilized chemical compounds, libraries of chemical compounds or arrays of chemical compounds, more particularly such compounds which are immobilized on a support; programs, more particularly computer programs, for screening of compounds such as nucleic acids, peptides and proteins; software for picture evaluation; and software for data evaluation; apparatus and apparatus for analysis for use in synthesis and/or immobilization of chemical products for industrial and scientific purposes, for production and analysis of patterns of surfaces and for screening of compounds such as nucleic acids, peptides and proteins, more particularly such apparatus and apparatus for analysis with integrated data analysis; diagnostic apparatus and analysis apparatus for synthesis and/or immobilization of chemical products for industrial and scientific purposes, for production and analysis of patterns of/on surfaces and for screening of compounds such as nucleic acids, peptides and proteins, more particularly such apparatus and analysis apparatus with integrated data analysis; chambers, more particularly chambers for hybridization; spotting apparatus

40 Custom chemical synthesis for others, namely, synthesis of nucleic acids, peptides, and proteins for industrial and scientific purposes, synthesis of immobilized chemical compounds, arrays, and libraries of nucleic acids, peptides and proteins for industrial and scientific purposes; immobilization of chemical products for others, namely, immobilization of nucleic acids, peptides, and proteins for industrial and scientific purposes, immobilization of arrays and libraries of nucleic acids, peptides and proteins for industrial and scientific purposes; custom manufacture, spotting, and design of biochips for others

42 Product research and development in the fields in the fields of biology, biochemistry, chemistry, medicine, veterinary medicine, pharmacology, genetics, cytogenetics, molecular biology, and biotechnology, namely, products used in the synthesis and immobilization of chemical products for industrial and scientific purposes, products research and development in the field of synthesis and immobilization of arrays and arrays of libraries of chemical compounds arranged on a support; scientific research, namely, screening for chemical interaction partners; product research and development in the field of chemical screening for interaction partners; development of new diagnostic technology for others in the fields of biology, biochemistry, chemistry, medicine, veterinary medicine, pharmacology, genetics, cytogenetics, molecular biology, and biotechnology; screening and development of arrays and libraries of arrays of immobilized chemical compounds arranged on a support for industrial and scientific purposes; development of computer software for use in screening and development of arrays and libraries of arrays of immobilized chemical compounds arranged on a support for industrial and scientific purposes; development of data processing software for use in product research and screening; database development and providing an on-line database in the field of product research and development in the fields of biology, biochemistry, chemistry, medicine, veterinary medicine, pharmacology, genetics, cytogenetics, molecular biology, and biotechnology

Color is not claimed as a feature of the mark.

Trademark Events

Apr 5, 2017

Teas Change Of Correspondence Received

Jan 13, 2017

Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed

Jan 13, 2017

Registered And Renewed (First Renewal - 10 Yrs)

Jan 13, 2017

Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted

Jan 10, 2017

Teas Response To Office Action-Post Reg Received

Sep 7, 2016

Post Registration Action Mailed - Sec. 8 & 9

Sep 6, 2016

Teas Section 8 & 9 Received

Oct 10, 2015

Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed

Mar 15, 2013

Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed

Mar 15, 2013

Registered - Partial Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.

Mar 1, 2013

Registered - Sec. 8 (6-Yr) & Sec. 15 Filed

Mar 15, 2013

Case Assigned To Post Registration Paralegal

Mar 1, 2013

Teas Section 8 & 15 Received

Dec 22, 2011

Teas Change Of Correspondence Received

Feb 3, 2010

Attorney Revoked And/Or Appointed

Feb 3, 2010

Teas Revoke/Appoint Attorney Received

Oct 24, 2007

Review Of Correspondence Complete

Oct 19, 2007

Paper Received

Oct 10, 2006

Registered-Principal Register

Aug 25, 2006

1(B) Basis Deleted; Proceed To Registration

Aug 25, 2006

Notice Of Allowance Cancelled

Aug 8, 2006

Paper Received

Mar 6, 2006

Extension 2 Granted

Mar 6, 2006

Extension 2 Filed

Mar 6, 2006

Teas Extension Received

Dec 21, 2005

Undeliverable Mail - No Action Taken

Dec 6, 2005

Paper Received

Dec 1, 2005

Extension 1 Granted

Sep 22, 2005

Extension 1 Filed

Nov 16, 2005

Petition To Revive-Granted

Oct 4, 2005

Petition To Revive-Received

Oct 4, 2005

Paper Received

Mar 22, 2005

Noa Mailed - Sou Required From Applicant

Dec 28, 2004

Published For Opposition

Dec 8, 2004

Notice Of Publication

Oct 19, 2004

Law Office Publication Review Completed

Oct 8, 2004

Assigned To Lie

Oct 6, 2004

Approved For Pub - Principal Register

Aug 3, 2004

Paper Received

Jun 18, 2004

Amendment From Applicant Entered

Jun 18, 2004

Unresponsive/Duplicate Paper Received

Jun 18, 2004

Paper Received

Feb 4, 2004

Final Refusal Mailed

Nov 24, 2003

Correspondence Received In Law Office

Dec 18, 2003

Case File In Ticrs

Nov 24, 2003

Paper Received

May 22, 2003

Inquiry As To Suspension Mailed

Nov 7, 2002

Letter Of Suspension Mailed

Sep 27, 2002

Correspondence Received In Law Office

Sep 23, 2002

Correspondence Received In Law Office

Mar 28, 2002

Non-Final Action Mailed

Mar 8, 2002

Assigned To Examiner